New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
A strategy for increasing shared decision making by physicians and older patients about colorectal cancer screening

A strategy for increasing shared decision making by physicians and older patients about colorectal cancer screening

byMassachusetts General HospitalCredit: CC0 Public DomainRegular screening for colorectal cancer—which current US guidelines advise beginning at age 45 for most people—is important for early can
World medicine December 16,2023
A strategy for increasing shared decision making by physicians and older patients about colorectal cancer screening

A strategy for increasing shared decision making by physicians and older patients about colorectal cancer screening

byMassachusetts General HospitalCredit: CC0 Public DomainRegular screening for colorectal cancer—which current US guidelines advise beginning at age 45 for most people—is important for early can
World medicine December 16,2023
FDA warns of rare cases of certain cancers linked to breast implants

FDA warns of rare cases of certain cancers linked to breast implants

The U.S. Food and Drug Administration on Thursday warned doctors and their patients about rare cases ofsquamous cell carcinomaand variouslymphomasdeveloping in the scar tissue
World medicine December 16,2023
FDA warns of rare cases of certain cancers linked to breast implants

FDA warns of rare cases of certain cancers linked to breast implants

The U.S. Food and Drug Administration on Thursday warned doctors and their patients about rare cases ofsquamous cell carcinomaand variouslymphomasdeveloping in the scar tissue
World medicine December 16,2023
Researchers discover cancer-associated fibroblasts induce drug sensitivity

Researchers discover cancer-associated fibroblasts induce drug sensitivity

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Min Yu (Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC),USC Norris Comprehensive Cancer Center
World medicine December 16,2023
Researchers discover cancer-associated fibroblasts induce drug sensitivity

Researchers discover cancer-associated fibroblasts induce drug sensitivity

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Min Yu (Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC),USC Norris Comprehensive Cancer Center
World medicine December 16,2023
Scientists uncover new therapeutic target for treating colorectal tumors

Scientists uncover new therapeutic target for treating colorectal tumors

byTokyo University of ScienceA new study by researchers from Japan and China has revealed that inhibiting DCIR, a C-type lectin receptor protein responsible for maintaining homeostasis in the im
World medicine December 16,2023
Scientists uncover new therapeutic target for treating colorectal tumors

Scientists uncover new therapeutic target for treating colorectal tumors

byTokyo University of ScienceA new study by researchers from Japan and China has revealed that inhibiting DCIR, a C-type lectin receptor protein responsible for maintaining homeostasis in the im
World medicine December 16,2023
Higher doses of CAR-T therapy bring survival advantage for young patients with hard-to-treat B-ALL

Higher doses of CAR-T therapy bring survival advantage for young patients with hard-to-treat B-ALL

byAmerican Society of HematologyCredit: CC0 Public DomainYoung people who received doses of tisagenlecleucel, a chimeric antigen receptor T cell (CAR-T) therapy, at the higher end of the FDA-app
World medicine December 16,2023
Higher doses of CAR-T therapy bring survival advantage for young patients with hard-to-treat B-ALL

Higher doses of CAR-T therapy bring survival advantage for young patients with hard-to-treat B-ALL

byAmerican Society of HematologyCredit: CC0 Public DomainYoung people who received doses of tisagenlecleucel, a chimeric antigen receptor T cell (CAR-T) therapy, at the higher end of the FDA-app
World medicine December 16,2023
Updated findings on a new approach to ER-positive/HER2-negative breast cancer

Updated findings on a new approach to ER-positive/HER2-negative breast cancer

byUniversity of California, Los AngelesThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 20
World medicine December 16,2023
Updated findings on a new approach to ER-positive/HER2-negative breast cancer

Updated findings on a new approach to ER-positive/HER2-negative breast cancer

byUniversity of California, Los AngelesThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 20
World medicine December 16,2023
Cancer-related fatigue linked to balance problems after chemotherapy for breast cancer

Cancer-related fatigue linked to balance problems after chemotherapy for breast cancer

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainFor many women who have undergone chemotherapy for breast cancer, cancer-related fatigue (CRF) is a persistent side effect—and one that c
World medicine December 16,2023
Cancer-related fatigue linked to balance problems after chemotherapy for breast cancer

Cancer-related fatigue linked to balance problems after chemotherapy for breast cancer

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainFor many women who have undergone chemotherapy for breast cancer, cancer-related fatigue (CRF) is a persistent side effect—and one that c
World medicine December 16,2023
Hiding in plain sight: Improved CAR T-cell therapy for T-cell acute lymphoblastic leukemia

Hiding in plain sight: Improved CAR T-cell therapy for T-cell acute lymphoblastic leukemia

bySt. Jude Children's Research HospitalCredit: CC0 Public DomainScientists at St. Jude Children's Research Hospital are improving chimeric antigen receptor (CAR) T-cell therapy. Their ne
World medicine December 16,2023
Hiding in plain sight: Improved CAR T-cell therapy for T-cell acute lymphoblastic leukemia

Hiding in plain sight: Improved CAR T-cell therapy for T-cell acute lymphoblastic leukemia

bySt. Jude Children's Research HospitalCredit: CC0 Public DomainScientists at St. Jude Children's Research Hospital are improving chimeric antigen receptor (CAR) T-cell therapy. Their ne
World medicine December 16,2023
Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma

Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma

by Impact JournalsRepresentative GPC3 expression by IHC. Credit: Muralidharan et al.A new research paper was published inOncotargeton August 3, 2022, entitled, "Glypican-3 (GPC3) is a
World medicine December 16,2023
Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma

Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma

by Impact JournalsRepresentative GPC3 expression by IHC. Credit: Muralidharan et al.A new research paper was published inOncotargeton August 3, 2022, entitled, "Glypican-3 (GPC3) is a
World medicine December 16,2023
Brain tumor study highlights differences among Hispanics

Brain tumor study highlights differences among Hispanics

by Sarah Avery,Duke UniversityCredit: Unsplash/CC0 Public DomainAlthough typically classified as a single ethnic group, people of Hispanic heritage have markedly different risks for brain tumors
World medicine December 16,2023
Brain tumor study highlights differences among Hispanics

Brain tumor study highlights differences among Hispanics

by Sarah Avery,Duke UniversityCredit: Unsplash/CC0 Public DomainAlthough typically classified as a single ethnic group, people of Hispanic heritage have markedly different risks for brain tumors
World medicine December 16,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com